HIVE Digital Technologies Ltd is a sustainable-energy-focused digital infrastructure company that provides infrastructure solutions through the operation of Tier-1 and Tier-3 data centers... Show more
HIVE Digital Technologies operates a "dual-engine" model that combines Bitcoin mining with an emerging HPC and AI cloud business. The company builds and operates data centers across Canada, Sweden, and Paraguay, positioning itself around green-energy-powered compute and, increasingly, Canadian sovereign AI infrastructure.
The strategic logic is that Bitcoin mining provides cash flow and power infrastructure, while the BUZZ HPC unit pursues higher-margin, contract-based GPU revenue. Management has stated that 100% of near-term growth capital is now directed toward HPC and AI, with the mining fleet managed for cash generation rather than expansion. A partnership with Bell Canada's AI Fabric platform gives HIVE a lower-capital path to deploy GPU clusters and access enterprise customers seeking domestic AI compute — a structural advantage in a market increasingly focused on data sovereignty and energy availability.
The competitive challenge is scale and capital. HIVE is competing against far larger, better-funded data center and AI infrastructure operators. Its market positioning will hinge on whether it can convert power and land assets into contracted recurring revenue without diluting shareholders excessively.
Several events could materially shape investor sentiment in the coming quarters. The next earnings report represents an immediate checkpoint for GPU cloud deployment progress, margin trends, and updates on contracted ARR. Management has targeted $200 million in GPU cloud ARR by the fourth quarter of calendar 2026, and progress against that milestone will be closely watched.
Contract signings are a central catalyst. HIVE recently announced a five-year GPU cloud agreement adding roughly $70 million in ARR and $350 million in total value, lifting contracted GPU cloud ARR to about $180 million. Analysts have noted that further conversions of memoranda of understanding into definitive agreements for larger GB200 and GB300 GPU clusters could extend this pipeline and improve revenue visibility.
The Greater Toronto Area gigafactory is the most consequential long-term catalyst. At an estimated total investment of roughly CAD 3.5 billion, the project's financing structure, construction timeline, and customer commitments will test the company's execution. Analyst ratings remain predominantly bullish: consensus coverage is a Strong Buy, with average price targets around $7 and a range from roughly $4.50 to $10. Notable recent actions include a Buy initiation from Chardan Capital at $7.50, an upward revision from Cantor Fitzgerald to $7, and a B. Riley target raise to $8. KBW remains the lone Hold-rated firm, having trimmed its target, which underscores that analyst expectations are optimistic but not unanimous.
HIVE's trajectory is shaped by two distinct macro regimes. On the AI side, demand for GPU compute, data center capacity, and sovereign AI infrastructure is being driven by enterprise adoption of generative AI and constrained power availability in key markets. Rising electricity demand and grid constraints favor operators that already control energized sites, which could support HIVE's colocation economics.
Interest rates and credit conditions are pivotal. Large data center buildouts are capital-intensive, and the cost of debt and project financing will influence HIVE's funding stack, dilution, and projected returns. The company has signaled a preference for roughly 20% down payments and debt-financed hardware, making its access to affordable capital a direct determinant of profitability.
On the Bitcoin side, cryptocurrency prices, network difficulty, and the block reward halving cycle continue to influence mining margins and cash generation. HIVE's improved mining efficiency has lowered its break-even cost, but revenue remains sensitive to Bitcoin price volatility. Geopolitical and regulatory factors — including the contested Swedish VAT matter and the broader push for domestic AI compute — add further nuance to the outlook.
Investors tracking HIVE's evolving story may also want to monitor short-term directional signals. Tickeron's Trend Prediction Engine is an AI-powered forecasting tool that helps traders assess whether a stock, ETF, or other asset may move bullish, bearish, or sideways over the next week or month. It is designed to help users spot developing trends, evaluate possible breakouts or reversals, and explore predictions across a broad range of tradable instruments, with searchable categories, historical context, and alert-oriented functionality. While fundamental catalysts drive long-term positioning, tools like this can add a complementary, data-driven layer to near-term market analysis.
Looking toward 2026 and beyond, HIVE's investment case rests on its ability to transform from a Bitcoin miner into a recurring-revenue AI infrastructure platform. The near-term focus is on reaching $200 million in GPU cloud ARR by late 2026 and roughly doubling its GPU fleet to about 11,000 units under management. Longer term, the gigafactory and colocation pipeline underpin the stated goal of $660 million in HPC-related ARR by end of 2028.
Structural themes to monitor include margin sustainability as newer-generation GPUs deliver greater profit per watt, the evolution of the funding stack and cost structure, and the pace of technology transitions across NVIDIA GPU generations. Competitive threats from larger data center operators and hyperscalers remain a key risk, as do capital allocation decisions that balance growth against shareholder dilution.
Analyst consensus reflects a constructive long-term view, though the wide dispersion in price targets signals genuine uncertainty about execution. If management can convert power assets and partnerships into funded, contracted revenue while preserving financial discipline, the narrative could shift toward a higher-quality, recurring-revenue profile. If buildout delays, financing costs, or regulatory issues persist, sentiment could turn more cautious despite the bullish consensus.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, HIVE has been closely correlated with CLSK. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if HIVE jumps, then CLSK could also see price increases.
| Ticker / NAME | Correlation To HIVE | 1D Price Change % | ||
|---|---|---|---|---|
| HIVE | 100% | -1.03% | ||
| CLSK - HIVE | 77% Closely correlated | -3.31% | ||
| KEEL - HIVE | 76% Closely correlated | -3.12% | ||
| CIFR - HIVE | 73% Closely correlated | -4.57% | ||
| BTBT - HIVE | 73% Closely correlated | -6.85% | ||
| COIN - HIVE | 73% Closely correlated | -2.74% | ||
More | ||||
a developer of cloud networking and enterprise Wi-Fi solution
Industry InvestmentBanksBrokers
The 50-day moving average for HIVE moved below the 200-day moving average on October 16, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HIVE as a result. In 63 of 81 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 78%.
The Moving Average Convergence Divergence Histogram (MACD) for HIVE turned negative on September 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 37 similar instances when the indicator turned negative. In 32 of the 37 cases the stock turned lower in the days that followed. This puts the odds of success at 86%.
HIVE moved below its 50-day moving average on October 05, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for HIVE crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIVE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
HIVE broke above its upper Bollinger Band on September 18, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for HIVE entered a downward trend on October 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 11 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 18 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Tickeron PE Growth Rating for this company is 13 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 66 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.972) is normal, around the industry mean (3.503). P/E Ratio (9.174) is within average values for comparable stocks, (8.788). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.000) settles around the average of (7.664) among similar stocks. P/S Ratio (2.169) is also within normal values, averaging (16.763).
The Tickeron Price Growth Rating for this company is 89 (best 1 - 100 worst), indicating slightly worse than average price growth. HIVE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HIVE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.